Gadicke Ansbert (CIK 0001134655)

Latest company ownership

Shares held
7,648,268
Last filed at
Feb 10, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q1 2025Q4
Shares held
4,983,843
Last filed at
Dec 4, 2025
Confidence Score
40.6
2026Q1
Confidence Score History
2021Q2 2026Q1
Shares held
4,381,062
Last filed at
Dec 12, 2024
Confidence Score
49.9
2025Q4
Confidence Score History
2021Q4 2025Q4
Shares held
3,882,485
Last filed at
Jul 13, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q2 2025Q4
ALT - Altimmune, Inc.
Role: 10% Owner
Shares held
2,428,171
Last filed at
Nov 5, 2010
Confidence Score
50.0
2026Q1
Confidence Score History
2010Q4 2026Q1
Shares held
1,732,573
Last filed at
Oct 11, 2017
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q4 2025Q4
VSTM - Verastem, Inc.
Role: Director
Shares held
76,190
Last filed at
Feb 3, 2012
Confidence Score
50.0
2026Q1
Confidence Score History
2012Q1 2026Q1

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 2, 2025 Dec 4, 2025 Werewolf Therapeutics, Inc. Other Sell 37.5 -199,732 -4.01% ✓ $183.3K
Nov 26, 2025 Dec 1, 2025 Werewolf Therapeutics, Inc. 10% Owner Sell 41.3 -141,927 -2.77% ✓ $136.9K
Nov 21, 2025 Nov 25, 2025 Werewolf Therapeutics, Inc. 10% Owner Sell 37.5 -195,666 -3.68% ✓ $179.6K
Nov 18, 2025 Nov 20, 2025 Werewolf Therapeutics, Inc. 10% Owner Sell 41.3 -160,103 -2.92% ✓ $147.9K
Nov 13, 2025 Nov 17, 2025 Werewolf Therapeutics, Inc. 10% Owner Sell 37.5 -209,652 -3.68% ✓ $200.7K
Nov 7, 2025 Nov 12, 2025 Werewolf Therapeutics, Inc. 10% Owner Sell 37.5 -213,529 -3.62% ✓ $241.3K
Nov 4, 2025 Nov 6, 2025 Werewolf Therapeutics, Inc. 10% Owner Sell 35.0 -242,890 -3.95% ✓ $295.8K
Oct 30, 2025 Nov 3, 2025 Werewolf Therapeutics, Inc. 10% Owner Sell 35.0 -295,043 -4.58% ✓ $391.6K
Oct 27, 2025 Oct 29, 2025 Werewolf Therapeutics, Inc. 10% Owner Sell 35.0 -276,017 -4.11% ✓ $446.4K
Mar 27, 2025 Apr 30, 2025 Werewolf Therapeutics, Inc. 10% Owner Sell 52.5 -4,386 -0.07% ✗ $4.6K
Dec 10, 2024 Dec 12, 2024 Entrada Therapeutics, Inc. 10% Owner Sell 20.0 -44,722 -1.01% ✗ $917.1K
Nov 2, 2021 Nov 4, 2021 Entrada Therapeutics, Inc. 10% Owner Buy 87.5 +100,000 2.31% ✗ $2M
Sep 16, 2021 Sep 20, 2021 Cullinan Therapeutics, Inc. Director Sell 53.8 -3,556 -0.05% ✓ $103.3K
Sep 14, 2021 Sep 16, 2021 Cullinan Therapeutics, Inc. Director Sell 47.5 -15,401 -0.19% ✓ $449.2K
Sep 9, 2021 Sep 13, 2021 Cullinan Therapeutics, Inc. Director Sell 46.3 -26,468 -0.33% ✓ $773.7K
Sep 3, 2021 Sep 8, 2021 Cullinan Therapeutics, Inc. Director Sell 42.5 -55,364 -0.69% ✓ $1.6M
Aug 31, 2021 Sep 2, 2021 Cullinan Therapeutics, Inc. Director Sell 46.3 -27,669 -0.34% ✓ $816.4K
Aug 27, 2021 Aug 31, 2021 Cullinan Therapeutics, Inc. Director Sell 42.5 -50,489 -0.63% ✓ $1.5M
Aug 23, 2021 Aug 25, 2021 Cullinan Therapeutics, Inc. Director Sell 42.5 -120,592 -0.51% ✓ $3.5M
Aug 11, 2021 Aug 12, 2021 Cullinan Therapeutics, Inc. Director Sell 53.8 -2,857 -0.03% ✓ $83K
Jul 9, 2021 Jul 13, 2021 Repare Therapeutics Inc. 10% Owner Sell 40.0 -62,079 -1.57% ✓ $2.1M
Jun 28, 2021 Jun 30, 2021 Repare Therapeutics Inc. 10% Owner Sell 46.3 -19,200 -0.48% ✓ $653.9K
Jun 24, 2021 Jun 28, 2021 Repare Therapeutics Inc. 10% Owner Sell 45.0 -28,688 -0.72% ✓ $961.5K
Jun 21, 2021 Jun 23, 2021 Repare Therapeutics Inc. 10% Owner Sell 40.0 -42,798 -1.06% ✓ $1.5M
Jun 17, 2021 Jun 21, 2021 Repare Therapeutics Inc. 10% Owner Sell 40.0 -41,518 -1.02% ✓ $1.4M
Jun 14, 2021 Jun 16, 2021 Repare Therapeutics Inc. 10% Owner Sell 50.0 -6,227 -0.15% ✓ $207.1K
Jun 8, 2021 Jun 10, 2021 Repare Therapeutics Inc. 10% Owner Sell 40.0 -61,430 -1.48% ✓ $2.1M
Jun 3, 2021 Jun 7, 2021 Repare Therapeutics Inc. 10% Owner Sell 40.0 -58,149 -1.38% ✓ $1.9M
May 28, 2021 Jun 2, 2021 Repare Therapeutics Inc. 10% Owner Sell 42.5 -38,098 -0.90% ✓ $1.2M
May 25, 2021 May 27, 2021 Repare Therapeutics Inc. 10% Owner Sell 42.5 -38,559 -0.90% ✓ $1.3M
May 21, 2021 May 24, 2021 Repare Therapeutics Inc. 10% Owner Sell 25.0 -324,869 -7.06% ✓ $11.3M
May 18, 2021 May 20, 2021 Repare Therapeutics Inc. 10% Owner Sell 40.0 -68,738 -1.47% ✓ $1.6M
May 4, 2021 May 6, 2021 Werewolf Therapeutics, Inc. 10% Owner Buy 92.5 +245,000 3.81% ✗ $3.9M
Mar 12, 2021 Mar 15, 2021 Repare Therapeutics Inc. 10% Owner Sell 15.0 -670,729 -6.68% ✗ $19.6M
Jan 7, 2021 Jan 14, 2021 Cullinan Therapeutics, Inc. Director Buy 96.3 +581,268 7.63% ✗ $6.3M
Jun 23, 2020 Jun 25, 2020 Repare Therapeutics Inc. 10% Owner Buy 100.0 +500,000 10.22% ✗ $10M
Oct 10, 2017 Oct 11, 2017 RHYTHM PHARMACEUTICALS, INC. 10% Owner Buy 92.5 +100,000 3.85% ✗ $1.7M
Feb 1, 2012 Feb 3, 2012 Verastem, Inc. Director Buy 95.0 +100,000 5.17% ✗ $1M
Nov 3, 2010 Nov 5, 2010 Altimmune, Inc. 10% Owner Buy 95.0 +430,000 7.27% ✗ $1.5M